Compare MGY & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGY | LIVN |
|---|---|---|
| Founded | 2017 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 2017 | 1993 |
| Metric | MGY | LIVN |
|---|---|---|
| Price | $23.74 | $63.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $26.00 | ★ $67.38 |
| AVG Volume (30 Days) | ★ 2.1M | 503.5K |
| Earning Date | 02-05-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | $1,320,826,000.00 | ★ $1,348,962,000.00 |
| Revenue This Year | $1.00 | $12.25 |
| Revenue Next Year | $1.20 | $6.68 |
| P/E Ratio | $13.19 | ★ N/A |
| Revenue Growth | 0.68 | ★ 8.63 |
| 52 Week Low | $19.09 | $32.48 |
| 52 Week High | $26.47 | $65.57 |
| Indicator | MGY | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 56.77 |
| Support Level | $22.18 | $60.79 |
| Resistance Level | $23.33 | $64.10 |
| Average True Range (ATR) | 0.68 | 1.64 |
| MACD | 0.21 | -0.11 |
| Stochastic Oscillator | 95.40 | 69.74 |
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.